tradmap

TRNS Transcat Inc

$87.78 +1.73%

Data as of close

Healthcare · Instruments For Meas & Testing Of Electricity & Elec Signals

Transcat Inc (TRNS) is a healthcare company in the Instruments For Meas & Testing Of Electricity & Elec Signals industry, with a market capitalization of $822 million. Shares last traded at $87.78, 11.1% below their 52-week high. Over the past year the stock is up 18.7%. TRNS trades at a price-to-earnings ratio of 152.83, above the Instruments For Meas & Testing Of Electricity & Elec Signals median of 50.03. Net profit margin is 1.5%, below the peer median of 2.6%. Revenue grew 19.2% year over year.

Market Cap
$822M
Shares Out
9.4M
EPS (TTM)
$0.36
P/E (TTM)*
152.83
P/S Ratio
2.36
P/B Ratio
2.71
Dividend / Share
—
Dividend Yield
—
52-Week High
$98.71
52-Week Low
$50.87
Volume (venue)
7,015
Avg Vol (3m, venue)
6,576.286

* P/E (TTM) = market cap ÷ net income over the trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year — the same basis as the peer table and the screener, so it can differ from price ÷ EPS.

Performance

1W
+5.48%
1M
-2.70%
3M
-4.31%
6M
+24.46%
YTD
+54.62%
1Y
+18.74%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
53.80
SMA (50)
$86.02
SMA (200)
$81.76
Price vs SMA50
+2.04%
Price vs SMA200
+7.36%
ATR (14)
$4.20

Full technical analysis (26 indicators, D/W/M) →

Financials

Revenue
$348M
Net Income
$5M
Gross Margin
31.1%
Operating Margin
3.8%
Net Margin
1.5%
Return on Equity
1.8%
Return on Assets
1.1%
Current Ratio
2.49
Debt / Equity
0.36
Revenue Growth (YoY)
+19.2%

Trailing twelve months where four consecutive quarters are reported, otherwise the latest fiscal year; revenue is the fiscal-year figure where quarterly revenue covers under half of it (typical for banks, insurers and REITs), and margins are taken on it; latest reported period ends 2026-06-27. Source: SEC EDGAR/XBRL.

Full financials — revenue, cash flow & debt over time →

Recent earnings

PeriodEPS (diluted)Reported
Q1 2027 $0.14 2026-08-04
Q4 2026 (derived) $0.20 2026-05-27
FY 2026 $0.57 2026-05-27
Q3 2026 -$0.12 2026-02-03
Q2 2026 $0.14 2025-11-05
Q1 2026 $0.35 2025-08-06

Q4 marked "derived" = fiscal-year EPS minus Q1–Q3 (10-Ks report only the annual figure); EPS is not strictly additive, so it can differ by a cent or two from the issuer's own Q4.

Full earnings history →

Instruments For Meas & Testing Of Electricity & Elec Signals peers

TRNS vs 10 industry peers (Instruments For Meas & Testing Of Electricity & Elec Signals), by market cap. Data as of close

P/E vs peers
152.83 / 50.03 med
+205% premium
P/S vs peers
2.36 / 3.26 med
-28% discount
Net margin vs peers
1.5% / 2.6% med
below median
1–10 of 10
TERTeradyne$40.7B29.668.1427.5%-4.82%
VLTOVeralto$28.1B28.084.8517.3%+4.18%
ITRIItron, Inc.$4.4B15.641.8912.1%+4.01%
COHUCohu Inc$2.3B—4.02-4.0%-4.89%
AEHRAehr Test Systems$1.9B—38.66-14.3%+8.04%
ALNTAllient Inc$1.4B50.032.495.0%-1.55%
TRNSTranscat Inc$822M152.832.361.5%+1.73%
FEIMFREQUENCY ELECTRONICS INC$740M276.3010.163.7%-3.26%
INTTINTEST CORP$175M295.731.440.5%-2.90%
DAIODATA I/O CORP$24M—1.37-50.1%-1.67%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.